Release Date: 07/09/22 16:17 Summary: Results of Scheme Meeting Price Sensitive: Yes Download Document 185.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%